Cardiogenic Shock Treatment: Why 40% of Patients S..

created a new article

10 w

Cardiogenic Shock Treatment: Why 40% of Patients Still Die Despite Medical Advances | #it

Cardiogenic Shock Treatment: Why 40% of Patients Still Die Despite Medical Advances

Cardiogenic Shock Treatment: Why 40% of Patients Still Die Despite Medical Advances

The gap between clinical capability and patient survival in cardiogenic shock remains dangerously wide, exposing a critical failure in care delivery m

Like

Comment

Share